Snipd home pageGet the app
Barron's Streetwise chevron_right

The First $100 Billion Drug

Jan 6, 2023
24:12
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
1
Introduction
00:00 • 4min
chevron_right
2
Biotech IPOs
04:25 • 2min
chevron_right
3
Lilly's New Drug Could Be the Key to Wining Insurance Coverage
06:20 • 2min
chevron_right
4
Can the Pfizer Moderna Be the First $100 Billion Drug in the Pharma Industry?
08:37 • 4min
chevron_right
5
Pfizer's COVID
12:24 • 3min
chevron_right
6
The Future of Everything Podcast
15:31 • 3min
chevron_right
7
The 10 Year Outlook for Cystic Fibrosis
18:08 • 2min
chevron_right
8
The Progress in Oncology and Immunotherapy
20:12 • 3min
chevron_right

BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time.

Learn more about your ad choices. Visit megaphone.fm/adchoices

HomeTop podcastsPopular guests